Showing results (101-110 of 149) with videos related to
Sort By:
Pageof 15
Leukemia Research Reports|March 6, 2014
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816HPeter Valent, Katharina Blatt, Gregor Eisenwort, et al.Haematologica|April 26, 2019
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosisGeorg Greiner, Michael Gurbisz, Franz Ratzinger, et al.Blood|August 4, 2012
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosisFelix Sahm, David Capper, Matthias Preusser, et al.Oncotarget|December 20, 2012
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AMLHarald Herrmann, Katharina Blatt, Junwei Shi, et al.ESMO Open|November 13, 2020
Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumoursMaximilian J Mair, Sahra Pajenda, Aysegül Ilhan-Mutlu, et al.Journal for Immunotherapy of Cancer|March 26, 2022
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinomaAngelika Martina Starzer, Gerwin Heller, Erwin Tomasich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2023
Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung CancerErwin Tomasich, Ariane Steindl, Christina Paiato, et al.Haematologica|January 19, 2011
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536Barbara Peter, Karoline V Gleixner, Sabine Cerny-Reiterer, et al.Clinical Nuclear Medicine|September 25, 2015
Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 PatientsMarius E Mayerhoefer, Chiara Giraudo, Daniela Senn, et al.Medcomm|July 8, 2025
Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC TrialRebecca Zirnbauer, Simon Hametner, Jutta Bergler-Klein, et al.Pageof 15